MYLAN ApS: Financial statements 2019
CVR: 28107013
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
MYLAN ApS (CVR 28107013) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 4,677 and a net result of DKK 1,952 compared with DKK 1,408 the year before. That is an increase of 66.1% compared with the year before. Equity in the 2019 report amounted to DKK 189,675. The solvency ratio was 53.2%.
- Gross Profit
- DKK 4,677
- Profit/Loss
- DKK 1,952
- Equity
- DKK 189,675
- Total Assets
- DKK 356,411
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 5 t. | 2 t. | 190 t. | 0 |
| 2018 | - | 3 t. | 1 t. | 188 t. | 0 |
| 2017 | - | 2 t. | 2 t. | 186 t. | 0 |
| 2016 | - | 3 t. | 2 t. | 185 t. | - |
| 2015 | - | - | 0 | 0 | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
MYLAN ApS has published its annual report for 2018. Gross profit came to DKK 2,815, and the net result was DKK 1,408.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.